You can buy or sell iBio and other stocks, options, ETFs, and crypto commission-free!
iBio, Inc., also called iBio, is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. Read More It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Simply Wall StFeb 28